42.55USD-2.94%Mkt Cap: 1.23B USDP/E: 9.66Last update: 2026-05-26
Inspire Medical Systems, Inc., a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA) in the United States and inter…
Industry Peers
Medical Devices151.38BUSDP/E 24.3
119.84BUSDP/E 36.2
86.12BUSDP/E 24.2
53.79BSEKP/E 100.1
52.47BSEKP/E 22.3
51.50BDKKP/E 21.8
50.54BUSDP/E 47.4
38.75BEURP/E 18.3
Indicators:|
Key Statistics
Company
Market Cap1.23B USD
Enterprise Value1.03B USD
Revenue (TTM)915.25M USD
Gross Profit778.76M USD
Net Income (TTM)145.42M USD
Revenue/Share31.43 USD
Last Price42.55 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees1.3K
CountryUS
SectorHealthcare
IndustryMedical Devices
ISINUS4577301090
Valuation
P/E (Trailing)9.66
P/E (Forward)33.97
PEG—
EV/EBITDA15.37
EV/Revenue1.13
P/S1.41
P/B1.63
EPS (TTM)4.40
EPS (Forward)1.32
52W Range
39.613% of range147.66
52W High147.66 USD
52W Low39.61 USD
Profitability
Gross Margin85.39%
Oper. Margin-0.55%
EBITDA Margin7.36%
Profit Margin15.95%
ROE18.62%
ROA16.03%
Growth
Revenue Growth1.60%
Earnings Growth—
Cash Flow & Leverage
Operating CF116.98M USD
CapEx (TTM)38.50M USD
FCF Margin9.35%
FCF Yield6.98%
Net Debt-254.28M USD
Net Debt/EBITDA-3.78
Balance Sheet
Debt/Equity0.04
Current Ratio6.34
Quick Ratio4.35
Book Value/Sh27.51 USD
Cash/Share9.851 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating2.6 (Hold)
Target (Mean)53.33 USD
Target Range45.00 USD – 65.00 USD
# Analysts12
Ownership
Shares Out.28.81M
Float28.42M
Insiders1.14%
Institutions123.91%
Short Interest
Short Ratio3.4d
Short % Float14.50%
Short % Out.11.06%
Shares Short3.19M
Short (prev mo.)3.20M
Technical
SMA 5051.88 (-18.0%)
SMA 20077.57 (-45.1%)
Beta0.83
S&P 52W Chg28.31%
Avg Vol (30d)1.22M
Avg Vol (10d)1.28M
Technical Indicators
RSI (14)—
MACD—
MACD Signal—
MACD Hist.—
BB Upper—
BB Middle—
BB Lower—
BB Width—
ATR (14)—
Vol Ratio (20d)—